IMPROVING FUZZY CLUSTERING WITH MULTI-VERSE OPTIMIZER FOR CLASSIFYING RESPIRATORY DISEASES: INFLUENZA, COVID-19, AND PNEUMONIA

Authors

  • Nguyen Thi Thuy Trang Ho Chi Minh City University of Industry and Trade Author
  • Dinh Nguyen Trong Nghia Ho Chi Minh City University of Industry and Trade Corresponding Author

DOI:

https://doi.org/10.62985/j.huit_ojs.vol26.no3.443

Keywords:

Fuzzy clustering, Multi-Verse Optimizer, Fuzzy C-Means, respiratory disease classification, medical diagnosis

Abstract

Accurately classifying respiratory diseases such as influenza, COVID-19, and pneumonia is crucial for diagnosis and treatment. However, due to the similarity in symptoms, grouping patients into distinct categories presents significant challenges. This study proposes an improvement to the fuzzy clustering algorithm by integrating the Multi-Verse Optimizer (MVO) to optimize cluster center positions, enhancing clustering quality and reducing misclassification among disease groups. By combining MVO's global optimization capability with the FCM method, the model achieves more precise disease cluster separation. Experimental results demonstrate that the proposed method outperforms traditional FCM, significantly improving clustering accuracy and disease group differentiation. This approach has the potential to be applied in supporting respiratory disease diagnosis, contributing to increased efficiency in medical practice.

References

[1] P. D. P. Silitonga, “Clustering of Patient Disease Data by Using K-Means Clustering,” International Journal of Computer Science and Information Security, vol. 15, no. 7, pp. 219–221, 2017.

[2] O. Pasin and S. Gonenc, “An Investigation into Epidemiological Situations of COVID-19 with Fuzzy K-Means and K-Prototype Clustering Methods,” Scientific Reports, vol. 13, no. 1, Art. no. 6255, 2023, doi: https://doi.org/10.1038/s41598-023-33214-y

[3] J. C. Bezdek, Pattern Recognition with Fuzzy Objective Function Algorithms. Plenum Press 1981, doi: https://doi.org/10.1007/978-1-4757-0450-1

[4] W. S. Utami, S. Artika, and R. Aldiansyah, “Data Clustering of Confirmed COVID-19 Patients Using Fuzzy C-Means,” International Journal of Engineering, Technology and Natural Sciences, vol. 5, no. 1, pp. 37–44, 2023.

[5] J. K. Deen, R. Ganesan, and A. Merline, “Fuzzy-C-Means Clustering Based Segmentation and CNN-Classification for Accurate Segmentation of Lung Nodules,” Asian Pacific Journal of Cancer Prevention, vol. 18, no. 7, pp. 1869–1873, 2017, doi: https://doi.org/10.22034/APJCP.2017.18.7.1869

[6] Y. Wu, H. Duan, and S. Du, “Multiple Fuzzy C-Means Clustering Algorithm in Medical Diagnosis,” Technology and Health Care, vol. 23, Suppl. 2, pp. S519–S527, 2015, doi: https://doi.org/10.3233/THC-150989

[7] K. Bhalla and A. Gosain, “Performance Analysis of Hybridized Fuzzy Clustering Algorithms Using Metaheuristic Algorithms,” in Lecture Notes in Networks and Systems, vol. 680, pp. 445–461, 2023, doi: https://doi.org/10.1007/978-981-99-2602-2_34

[8] J. Zhang and Z. Ma, “Hybrid Fuzzy Clustering Method Based on FCM and Enhanced Logarithmical PSO (ELPSO),” Computational Intelligence and Neuroscience, vol. 2020, no. 1, Art. no. 1386839, 2020, doi: https://doi.org/10.1155/2020/1386839

[9] S. Tongbram et al., “A Novel Image Segmentation Approach Using FCM and Whale Optimization Algorithm,” Journal of Ambient Intelligence and Humanized Computing, vol. 12, pp. 11565–11580, 2021, doi: https://doi.org/10.1007/s12652-020-02762-w

[10] S. Mirjalili, S. M. Mirjalili, and A. Hatamlou, “Multi-Verse Optimizer: A Nature-Inspired Algorithm for Global Optimization,” Neural Computing and Applications, vol. 27, no. 2, pp. 495–513, 2016, doi: https://doi.org/10.1007/s00521-015-1870-7

[11] S. M. Ross, Introduction to Probability Models, New York, Academic Press, 2014.

[12] N. Chen et al., “Epidemiologic and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China,” The Lancet, vol. 395, no. 10223, pp. 507–513, 2020, doi: https://doi.org/10.1016/S0140-6736(20)30211-7

[13] T. M. Uyeki et al., “Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza,” Clinical Infectious Diseases, vol. 68, no. 6, pp. 895–902, 2019, doi: https://doi.org/10.1093/cid/ciy874

[14] J. P. Metlay et al., “Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America,” American Journal of Respiratory and Critical Care Medicine, vol. 200, no. 7, pp. e45–e67, 2019, doi: https://doi.org/10.1164/rccm.201908-1581ST

[15] D. Wang et al., “Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China,” JAMA, vol. 323, no. 11, pp. 1061–1069, 2020, doi: https://doi.org/10.1001/jama.2020.1585

[16] Y. Liu et al., “Association between age and clinical characteristics and outcomes of COVID-19,” European Respiratory Journal, vol. 55, no. 5, Art. no. 2001112, 2020, doi: https://doi.org/10.1183/13993003.01112-2020

Published

2026-06-28

Issue

Section

Information Technology